Literature DB >> 11302882

Reversible posterior leucoencephalopathy syndrome in systemic lupus and vasculitis.

A Primavera1, D Audenino, N Mavilio, L Cocito.   

Abstract

OBJECTIVES: Reversible posterior leucoencephalopathy syndrome (RPLS) may develop in patients with renal insufficiency, hypertension, and immunosuppression, and is managed by prompt antihypertensive and anticonvulsant treatment. Four patients with renal insufficiency and fluid overload associated with Wegener's granulomatosis (one patient) and systemic lupus erythematosus (SLE) (three patients) are described, whose clinical picture and neuroimaging indicated RPLS. CASE REPORTS: All patients had headache, seizures, visual abnormalities, and transient motor deficit, and were hypertensive at the onset of the symptoms. Head computed tomography (CT) scan and magnetic resonance imaging showed predominantly posterior signal abnormalities, which were more conspicuous on T(2) weighted spin echo images than on CT scan. All patients had some form of cytotoxic treatment shortly before the syndrome developed, and dramatically responded to blood pressure control and anticonvulsant treatment. In two patients with SLE, dialysis was required for renal insufficiency. DISCUSSION: Follow up neuroimaging studies showed almost complete resolution of signal abnormalities, and suggested that RPLS was associated with cerebral oedema without concomitant infarction. The treatment of hypertension and neurotoxic condition such as uraemia appears of primary importance, while immunosuppressive treatment may cause further damage of the blood-brain barrier.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11302882      PMCID: PMC1753651          DOI: 10.1136/ard.60.5.534

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  15 in total

1.  [Pregnancy-linked endotheliopathy. A disease with multiple variants?].

Authors:  F Sextro; S Klimpe; G F Hamann
Journal:  Nervenarzt       Date:  2012-04       Impact factor: 1.214

2.  [Acute bilateral loss of vision in posterior reversible encephalopathy syndrome].

Authors:  K S Bonsel; I Oberacher-Velten; K Hufendiek; H Jägle
Journal:  Ophthalmologe       Date:  2013-03       Impact factor: 1.059

3.  Posterior reversible encephalopathy syndrome in a patient with ANCA-associated vasculitis.

Authors:  Alexandra Gonzalez Fuentes; Ashwini Komarla; John I Gomez
Journal:  Rheumatol Int       Date:  2010-07-10       Impact factor: 2.631

Review 4.  Posterior reversible encephalopathy syndrome, part 1: fundamental imaging and clinical features.

Authors:  W S Bartynski
Journal:  AJNR Am J Neuroradiol       Date:  2008-03-20       Impact factor: 3.825

Review 5.  Immunotherapies for Neurological Manifestations in the Context of Systemic Autoimmunity.

Authors:  Eleni I Kampylafka; Harry Alexopoulos; Marinos C Dalakas; Athanasios G Tzioufas
Journal:  Neurotherapeutics       Date:  2016-01       Impact factor: 7.620

6.  Posterior reversible encephalopathy syndrome: associated clinical and radiologic findings.

Authors:  Jennifer E Fugate; Daniel O Claassen; Harry J Cloft; David F Kallmes; Osman S Kozak; Alejandro A Rabinstein
Journal:  Mayo Clin Proc       Date:  2010-05       Impact factor: 7.616

7.  Temporary Visual Loss Due to Posterior Reversible Encephalopathy Syndrome in the Case of an End-Stage Renal Disease Patient.

Authors:  Michael Chia-Yen Chou; Chia-Yi Lee; Shih-Chun Chao
Journal:  Neuroophthalmology       Date:  2017-05-30

Review 8.  Eosinophilic granulomatosis with polyangiitis (EGPA) and PRES: a case-based review of literature in ANCA-associated vasculitides.

Authors:  A M Marra; G Barilaro; V Villella; M Granata
Journal:  Rheumatol Int       Date:  2015-04-03       Impact factor: 2.631

Review 9.  The multifactorial origin of posterior reversible encephalopathy syndrome in cyclophosphamide-treated lupus patients.

Authors:  Tatjana Zekić; Mirjana Stanić Benić; Ronald Antulov; Igor Antončić; Srđan Novak
Journal:  Rheumatol Int       Date:  2017-10-17       Impact factor: 2.631

10.  The posterior reversible encephalopathy syndrome.

Authors:  K Mandal Sanjay; P Chakraborty Partha
Journal:  Indian J Pediatr       Date:  2008-09-22       Impact factor: 1.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.